7 Publikationen
-
2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2977978Goon, P., Sauzet, O., Schuermann, M., Oppel, F., Shao, S. Y., Scholtz, L. - U., Sudhoff, H., et al. (2023). Recurrent Respiratory Papillomatosis (RRP)—Meta-analyses on the use of the HPV vaccine as adjuvant therapy. npj Vaccines, 8(1), 49. https://doi.org/10.1038/s41541-023-00644-8
-
2023 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2968186Shao, S., Scholtz, L. - U., Gendreizig, S., Martínez-Ruiz, L., Florido, J., Escames, G., Schürmann, M., et al. (2023). Primary head and neck cancer cell cultures are susceptible to proliferation of Epstein-Barr virus infected lymphocytes. BMC Cancer, 23(1), 47. https://doi.org/10.1186/s12885-022-10481-y
-
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2965718Oppel, F., Shao, S., Gendreizig, S., Kühnel, P., Przybycin, V., Hain, C., Schmidt, P., et al. (2022). Head and neck cancer cells can differentiate and resemble their tissue of origin. Proceedings: AACR Annual Meeting 2022; April 8-13, 2022; New Orleans, LA, Cancer Research, 82, 111-111. American Association for Cancer Research (AACR). https://doi.org/10.1158/1538-7445.AM2022-111
-
2022 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2967816Gendreizig, S., Neumann, J. M., Loganathan, L., Hose, L., Goon, P., Oppel, F., Brasch, F., et al. (2022). P35 Spatial proteomics and metabolomics investigations in head & neck cancers. Oral Oncology, 134, 106164. https://doi.org/10.1016/j.oraloncology.2022.106164
-
2022 | Kurzbeitrag Konferenz / Poster | Veröffentlicht | PUB-ID: 2967817Oppel, F., Gendreizig, S., Kühnel, P., Martínez-Ruiz, L., Shao, S., Schmidt, P., Hain, C., et al. (2022). P28 Head and neck cancer cells differentiate resembling their tissue of origin. In Amsterdam University Medical Centers (Ed.), Oral Oncology: Vol. 134. Abstracts of the 4th International Symposium on HPV Infection in Head and Neck Cancer Latest Advances in Biomarker-driven Management Elsevier . https://doi.org/10.1016/j.oraloncology.2022.106159
-
2022 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2965703Oppel, F., Shao, S., Gendreizig, S., Zimmerman, M. W., Schürmann, M., Viyof Ful, F., Goon, P., et al. (2022). p53 pathway inactivation drives SMARCB1-deficient p53-wildtype epithelioid sarcoma onset indicating therapeutic vulnerability through MDM2 inhibition. Molecular Cancer Therapeutics. https://doi.org/10.1158/1535-7163.MCT-21-0770
-
2020 | Zeitschriftenaufsatz | Veröffentlicht | PUB-ID: 2951607Oppel, F., Görner, M., & Sudhoff, H. (2020). The Potential of Tumor Debulking to Support Molecular Targeted Therapies. Frontiers in Oncology, 10, 801. https://doi.org/10.3389/fonc.2020.00801